Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes

Leukemia
M KitagawaKatsuiku Hirokawa

Abstract

To clarify whether regulatory cytokines inhibit hematopoiesis in patients with myelodysplastic syndromes (MDS), malignancies characterized by the formation of cytopenias despite the presence of cellular bone marrow, expression of TNF-alpha and IFN-gamma by bone marrow cells was investigated using specific reverse transcriptase-polymerase chain reaction assays. An enhanced expression of the mRNA for TNF-alpha was observed in most of the samples from MDS patients (11/14, 79%), whereas no enhancement was observed in bone marrow samples from AML (0/6), CML (0/2) or control cases (0/8). The expression of IFN-gamma was also enhanced in some of MDS cases (5/12, 42%) while AML (0/5), CML (0/2) and control cases (0/6) showed very low levels of IFN-gamma mRNA expression. Immunohistochemical examination confirmed the scattered presence of TNF-alpha or IFN-gamma producing cells in the bone marrow of MDS patients. The majority of these cells were CD68-positive macrophage lineage cells. These results suggested that disruption of hematopoiesis in MDS might be caused by enhanced production of inhibitory regulatory cytokines especially TNF-alpha and occasionally IFN-gamma by bone marrow macrophages.

Citations

Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Dec 4, 2004·Cancer Immunology, Immunotherapy : CII·Masanobu KitagawaKatsuiku Hirokawa
Mar 1, 2006·Current Hematologic Malignancy Reports·Mikkael A Sekeres, Alan List
Jul 31, 2013·Blood Cells, Molecules & Diseases·Wei DuQishen Pang
Oct 21, 2004·Best Practice & Research. Clinical Haematology·Ghulam J Mufti
Aug 23, 2002·Leukemia Research·Carlos M de Castro
Sep 4, 1999·Leukemia Research·Y Yoshida, G J Mufti
Mar 22, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·F Zorat, G Pozzato
Feb 11, 2005·The New England Journal of Medicine·Alan ListJerome B Zeldis
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·A Mario MarcondesH Joachim Deeg
Jan 31, 2007·International Journal of Hematology·Shuchang ChenMei Guan
Dec 18, 2013·Oncogene·H K EliasU Steidl
Nov 26, 2002·American Journal of Hematology·Takahiro OkamotoEizo Kakishita
Jan 7, 2016·Expert Review of Hematology·Abdallah Abou ZahrAmer M Zeidan
Jul 2, 2005·Expert Opinion on Emerging Drugs·Nnenna Osuji, R Pettengell
Mar 23, 2011·Expert Opinion on Drug Safety·Prerna Mewawalla, Constantin A Dasanu
Aug 9, 2005·Expert Opinion on Emerging Drugs·Philip J Nivatpumin, Steven D Gore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.